B-cell Lymphoblastic Leukemia

• CLINICAL_TRIALS research · 2024-12-16
  Clinical Trial Update: CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating CD19 and CD22 bispecific CAR T cells for relapsed/refractory B-cell hematologic tumors, currently recruiting.

• CLINICAL_TRIALS trial_result · 2017-05-22
  Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]

  Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…